Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Thank you for selecting your broker
We are redirecting you to the Broker Center now
Welcome to Please help us personalize your experience.

Select the one that best describes you
Thank you for your submission, we hope you enjoy your experience

Halloween Sale: Pro Price Slashed — Redeem Now

Etfdb logo
  • ETF
  • IHF
    Pricing Data
    Change: $1.9 (-0.02%)
    Time: 10/27/16
    Previous Close: $119.89
  • Category
  • Health & Biotech Equities
Last Updated:



Trading Data

Open: - Volume -
Day Lo - Day Hi -
  • 52 Week Lo: $105.38
  • 52 Week Hi: $132.74
  • AUM: $539.7 M
  • Shares: 4.5 M

Investment Themes

Historical Trading Data

  • 1 Month Avg. Volume: 173,817
  • 3 Month Avg. Volume: 130,097

Alternative ETFs in the Health & Biotech Equities Category

Sign Up for Pro to Unlock Data Sign Up
Type Ticker Expense Ratio Assets Avg. Daily Vol YTD Return
Largest (AUM)
Most Liquid (Volume)
Top YTD Performer

Analyst Report

This ETF offers exposure to health care providers, a narrow sub-sector of the health care industry that may be subject to unique regulatory risks. Given the extremely narrow focus of this fund, IHF probably doesn't belong in a long-term portfolio in any major amount, though this fund can be useful for those investors looking to implement a tactical tilt towards health care providers or perhaps as part of a long/short pairs trade. Not surprisingly, IHF is somewhat limited in terms of individual security diversification; the underlying portfolio is not extremely deep, and a few of the bigger names in the basket receive significant allocations in this fund. IHF is probably to granular for the vast majority of investors out there, but for those with a very specific objective it can be a useful tool for fine tuning portfolio exposure. Those looking for broader health care representation will prefer funds such as VHT or XLV; the equal-weighted RYH is also an interesting option. There are a number of other hyper-targeted options available under the health care umbrella, including medical devices (IHI), pharmaceuticals (IHE), and health care equipment (XHE).

Realtime Rating

Sign Up for Pro to Unlock Data Sign Up

Realtime Rating Summary

The adjacent table gives investors an individual Realtime Rating for IHF on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Compare to another ETF

View the Category Report

IHF Overall Realtime Rating:

A+ Overall Rated ETF:

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity B+ n/a
Expenses B+ n/a

Knowledge Centers

IHF In-Depth Analysis

The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb Category.

IHF Holdings

Filings Data as of: Oct 04, 2016
Sign Up for Pro to Unlock Data Sign Up

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb Category.

Number of Holdings
Category Low
Category High
% Assets in Top 10
Category Low
Category High

Asset Allocation

Asset Percentage
U.S. Stocks 99.49%
International Stocks 0.44%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 0.07%
Other 0.0%

Sector Breakdown

Sector Percentage
Health Care 91.97%
Industrials 4.12%
Technology 3.02%
Financial Services 0.81%
Real Estate 0.0%
Consumer Defensive 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Communication Services 0.0%
Utilities 0.0%

Market Cap Breakdown

Market Cap Percentage
Giant 14.25%
Large 35.39%
Medium 22.78%
Small 20.46%
Micro 7.04%

Region Breakdown

Region Percentage
U.S. 99.49%
Latin America 0.44%
Middle East 0.0%
Japan 0.0%
Australia 0.0%
Africa 0.0%
Europe 0.0%
Asia (Developed) 0.0%
Canada 0.0%
Asia (Emerging) 0.0%

Market Tier Breakdown

Region Percentage
Developed 99.93%
Emerging 0.0%

Country Breakdown

Country Percentage
United States 99.49%
Puerto Rico 0.44%
Other 0.07%

IHF Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up

Expenses Ratio Analysis

ETF Average
ETF Wtd. Average
Category Average
Expense Ratio
Category Low
Category High

Commission Free Trading

This ETF is not currently available for commission free trading on any platforms.

Category Commission Free Trading

There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:

IHF Performance

This section shows how this ETF has performed relative to its peer group ETFdb Category.

1 Week Return
Category Low
Category High
4 Week Return
Category Low
Category High
13 Week Return
Category Low
Category High
26 Week Return
Category Low
Category High
Year to Date Return
Category Low
Category High
1 Year Return
Category Low
Category High
3 Year Return
Category Low
Category High
5 Year Return
Category Low
Category High

Brought to You by Mitre Media


The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of IHF relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

IHF Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
P/E Ratio
Category Low
Category High

As of Aug 25 2016

IHF Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb Category.

Sign Up for Pro to Unlock Data Sign Up
Dividend Date
Annual Dividend Rate
Annual Dividend Yield
Category Low
Category High

As of Aug 25, 2016

IHF Technicals

Sign Up for Pro to Unlock Data Sign Up

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb Category.

5 Day Volatility
Category Low
Category High
20 Day Volatility
Category Low
Category High
50 Day Volatility
Category Low
Category High
200 Day Volatility
Category Low
Category High
Category Low
Category High
Standard Deviation
Category Low
Category High


  • 20 Day MA: $121.75
  • 60 Day MA: $123.24
  • MACD 15 Period: -3.41
  • MACD 100 Period: -7.09
  • Williams % Range 10 Day: 97.02
  • Williams % Range 20 Day: 97.43
  • RSI 10 Day: 30
  • RSI 20 Day: 38
  • RSI 30 Day: 41
  • Ultimate Oscillator: 36

Bollinger Brands

  • Lower Bollinger (10 Day): $118.39
  • Upper Bollinger (10 Day): $124.61
  • Lower Bollinger (20 Day): $119.06
  • Upper Bollinger (20 Day): $124.52
  • Lower Bollinger (30 Day): $119.51
  • Upper Bollinger (30 Day): $125.18

Support & Resistance

  • Support Level 1: $117.29
  • Support Level 2: $116.58
  • Resistance Level 1: $119.23
  • Resistance Level 2: $120.46


  • Stochastic Oscillator %D (1 Day): 23.21
  • Stochastic Oscillator %D (5 Day): 25.53
  • Stochastic Oscillator %K (1 Day): 36.72
  • Stochastic Oscillator %K (5 Day): 42.83

Fact Sheet

Fact sheets are issued by the ETF provider and framed by Information contained within the fact sheet is not guaranteed to be timely or accurate.

2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.